Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10 N05.4 is a billable code used to indicate a diagnosis of unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis.
Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis is characterized by the presence of nephritic syndrome symptoms, including hematuria, proteinuria, and hypertension, alongside diffuse endocapillary proliferation of glomerular cells. This condition often results from various underlying etiologies, including infections, autoimmune diseases, or idiopathic causes. Clinically, patients may present with edema, oliguria, and elevated serum creatinine levels. Renal biopsy findings typically reveal glomerular hypercellularity, often with an increase in mesangial and endothelial cells, and may show immune complex deposition. Management involves addressing the underlying cause, controlling blood pressure, and may include corticosteroids or immunosuppressive therapy depending on the severity and etiology. Regular monitoring of renal function and proteinuria is essential to assess treatment response and progression of the disease.
Detailed clinical history, laboratory results, and imaging studies.
Patients presenting with acute kidney injury, chronic kidney disease, or unexplained proteinuria.
Ensure accurate documentation of renal biopsy findings and treatment plans.
Comprehensive patient history, physical examination findings, and management plans.
Management of patients with systemic diseases affecting the kidneys.
Document any comorbid conditions that may influence renal function.
Used when nephritic syndrome is suspected and renal histology is needed.
Indication for biopsy, consent, and procedure details.
Nephrology specialists should document the rationale for biopsy.
Key symptoms include hematuria, proteinuria, hypertension, and edema. Patients may also experience oliguria and renal insufficiency.
